BCOR and acute myeloid leukemia: We analyzed a large cohort of newly diagnosed and intensively treated AML patients according to their mutational status of BCOR and BCORL1. The respective proportions of mBCOR and mBCORL1 in the cohort were comparable to those reported in recent studies [6,21,26,27].